|
Volumn 91, Issue , 1997, Pages 40-44
|
Responses to T cell tolerogenic peptides
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLERGEN;
ALLERVAX CAT;
FREUND ADJUVANT;
GAMMA INTERFERON;
IMMUNOGLOBULIN E;
IMMUNOGLOBULIN G;
INTERLEUKIN 2;
INTERLEUKIN 4;
MYELIN BASIC PROTEIN;
PEPTIDE FRAGMENT;
UNCLASSIFIED DRUG;
EPITOPE;
PEPTIDE;
ALLERGY;
ANTIBODY BLOOD LEVEL;
ANTIGEN PRESENTATION;
CLINICAL TRIAL;
CLONAL ANERGY;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
IMMUNOTHERAPY;
INTRAVENOUS DRUG ADMINISTRATION;
MEDIATOR RELEASE;
PROTEIN PROTEIN INTERACTION;
SUBCUTANEOUS DRUG ADMINISTRATION;
T LYMPHOCYTE;
T LYMPHOCYTE ACTIVATION;
ANIMAL;
ARTICLE;
BIOLOGICAL MODEL;
DESENSITIZATION;
HYPERSENSITIVITY;
IMMUNOLOGICAL TOLERANCE;
IMMUNOLOGY;
ANIMALS;
DESENSITIZATION, IMMUNOLOGIC;
EPITOPES, T-LYMPHOCYTE;
HUMANS;
HYPERSENSITIVITY;
IMMUNE TOLERANCE;
MODELS, BIOLOGICAL;
PEPTIDES;
T-LYMPHOCYTES;
|
EID: 0031300101
PISSN: 09368671
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (1)
|
References (14)
|